Trial Profile
A randomised study of CX-01 for the treatment of small cell lung cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Dociparstat sodium (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 19 Aug 2015 New trial record